FDA Drug recall D-1611-2014
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only
- FDA Drug
- Class II
- terminated
- Published 2014-10-08
On 2014-10-08 the FDA classified a Class II recall of CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only by Abbvie, citing presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1611-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-09-15 |
| Published | 2014-10-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Abbvie |
| Distribution | US |
Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Reason
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Identifiers
| ndc | 0032-1203-70 |
|---|---|
| ndc | 0032-1203-64 |
| ndc | 0032-1206-07 |
| ndc | 0032-1206-01 |
| ndc | 0032-1206-56 |
| ndc | 0032-1212-07 |
| ndc | 0032-1212-01 |
| ndc | 0032-1212-46 |
| ndc | 0032-1212-13 |
| ndc | 0032-1224-07 |
| ndc | 0032-1224-01 |
| ndc | 0032-1224-46 |
| ndc | 0032-3016-28 |
| ndc | 0032-3016-13 |
| ndc | 0032-3016-50 |
| ndc | 0032-3016-12 |
| ndc | 0032-0045-70 |
| ndc | 0032-0045-30 |
| ndc | 0032-0046-30 |
| ndc | 0032-0046-70 |
| ndc | 0032-0047-30 |
| ndc | 0032-0047-70 |
| ndc | 0032-2636-70 |
| ndc | 0032-2636-01 |
| ndc | 0032-2636-30 |
| ndc | 0032-2637-70 |
| ndc | 0032-2637-01 |
| ndc | 0032-2637-30 |
| code_info | Lot #: 1020156; Expiry: 3/31/2016 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1611-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.